Oregon 2025 Regular Session

Oregon Senate Bill SB1003

Introduced
2/11/25  
Refer
2/11/25  
Refer
4/17/25  
Refer
6/10/25  

Caption

Relating to death with dignity; prescribing an effective date.

Impact

The bill is set to impact Oregon state laws by modifying existing frameworks within the death with dignity legislation. Key changes include a reduction in the mandatory waiting period before a prescription can be issued from fifteen days to seven, thus expediting the process for terminally ill patients seeking assistance in dying. Furthermore, the amendments specify that no discrimination should occur in insurance policies based on a patient's decision to utilize the act. This aligns Oregon's laws with contemporary medical and ethical standards surrounding end-of-life care.

Summary

Senate Bill 1003 amends the existing Oregon Death With Dignity Act, primarily addressing the provisions that govern how qualified patients can request medication to end their life in a humane and dignified manner. The amendments include adjustments to waiting periods, the responsibilities of attending and consulting practitioners, and protocols for patient consent. The modifications aim to clarify patient rights and ensure compliance with statutory procedures, reflecting ongoing discussions surrounding the ethical implications of assisted dying.

Sentiment

General sentiment on SB 1003 is mixed, with strong support from advocates for the terminally ill who argue that the changes will provide them with greater autonomy and relief from suffering. However, there are also significant points of contention among conservative groups and some medical professionals who fear that the amendments could weaken patient safeguards. The discussions revealed a deep divide regarding the moral and ethical implications of assisted dying, highlighting a broader societal debate about the right to die versus the sanctity of life.

Contention

A notable point of contention revolves around the proposed changes to the waiting period, which some fear could hasten decisions for patients who might be uncertain or depressed. Critics express concern that reducing the waiting time may compromise thorough evaluation processes by healthcare professionals. Additionally, debates focus on the establishment of protections for healthcare providers, ensuring that no penalties accrue to those who choose not to participate in the act on moral grounds. This tension underscores the complex interplay between legal, ethical, and medical perspectives in end-of-life care policies.

Companion Bills

No companion bills found.

Previously Filed As

OR HB3004

Relating to renewable energy; prescribing an effective date.

OR SB891

Relating to death with dignity.

OR HB4010

Relating to health care; prescribing an effective date.

OR HB4130

Relating to the practice of health care; prescribing an effective date.

OR HB3574

Relating to the practice of health care; prescribing an effective date.

OR SB1537

Relating to housing; prescribing an effective date.

OR SB189

Relating to health care; and prescribing an effective date.

OR SB226

Relating to nursing; and prescribing an effective date.

OR HB3444

Relating to health care; prescribing an effective date.

OR HB2009

Relating to revenue; and prescribing an effective date.

Similar Bills

OR SB891

Relating to death with dignity.

VT H0075

An act relating to clinician participation in patient choice at end of life and DNR/COLST orders

RI S0701

Allows advanced practice registered nurses, physician assistants, and physicians who are and are not licensed in Rhode Island to provide telemedicine services to patients who are in the state when those services are rendered.

WV HB3070

Relating to the requirement of insurance coverage for a nonopioid drug for a person diagnosed with a substance use disorder

OR HB3799

Relating to medical treatments with investigational products.

OR SB236

Relating to controlled substances; and declaring an emergency.

OR HB3046

Relating to pharmacy; prescribing an effective date.

OR HB3258

Relating to prescription drug monitoring; and prescribing an effective date.